Skip to content
For laboratory research use only · Not for human or veterinary use · Qualified buyers only
Peptides

What Is NAD+? Identity, Catalog Form, and Laboratory Documentation

A research-use introduction to NAD+ as a laboratory material — a coenzyme, not a peptide — covering identity, catalog form, and the documents that should accompany a lot.

What Is NAD+? Identity, Catalog Form, and Laboratory Documentation

NAD+ (nicotinamide adenine dinucleotide) is a nucleotide-derived coenzyme used as a defined laboratory material. It is not a peptide. It appears in a research-material catalog because laboratories order it alongside other documented reagents, not because the name belongs to the same chemical class.

Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only.

Why the chemical class matters in a purchase file

The current page address still contains the word “peptide.” That is a historical slug and should not be read as a classification. A quotation, a label, and a report should name NAD+ (or the exact catalog form being offered) and should not bury the identity under a family label from a neighboring product line.

Form also matters. Catalog presentations may differ in specification, salt, or fill. Write the intended form on the procurement brief before comparing prices. A lower quotation is not comparable if it describes a different specification or a different quantity basis.

Identity, purity, and content are different measurements

Because NAD+ is not a peptide, some peptide-specific talking points do not transfer automatically. The useful habit still does: separate identity, purity, content, and any other risk-based tests your organization requires. A chromatographic purity headline does not by itself state how much target material is in a vial. An identity method should be suited to this analyte, not copied uncritically from a peptide template.

For a general comparison of chromatographic purity work and mass-spectrometric identity work in lot review, see HPLC vs Mass Spectrometry for Peptide Lot Review. Use that article for the logic of complementary methods. Confirm with the report in hand that the method was actually applied to the NAD+ sample being offered.

Literature background is not a lot specification

NAD+ is widely discussed in redox chemistry, enzyme cofactor studies, and related laboratory models. That literature can help a reader understand why a laboratory might order the material. It does not identify the lot on the bench, and it does not justify claims about use in people.

If a paper is used as background, check the form the authors used and whether they reported documentation for their test article. Do not treat a catalog name as proof that you hold the same material. Adjacent catalog items studied in related laboratory themes, such as MOTS-c, should be specified and documented on their own terms.

Lot documents and catalog pages

Checks for an NAD+ research-material lot file
Question What to confirm
Named form NAD+ or the exact catalog form, including any stated salt or presentation — not a generic “peptide” label.
Identity A method suited to this analyte, tied to a sample identifier that matches the offered lot.
Purity or related quality data The method, conditions, and supporting trace or data, not only a headline number.
Content A quantity or assay result with units if the protocol requires it.
Lot match Product name, specification, supplier lot, laboratory sample identifier, and report date should agree.

How to Read a Peptide COA remains useful as a checklist for matching a report to a quotation, even when the analyte is not a peptide. Third-Party Peptide Testing, Explained covers independence and scope.

Catalog specifications are on the NAD+ wholesale specifications page. Reference reports are in the NAD+ COA Library; confirm current-lot applicability before ordering. Other catalog materials are listed in the product directory.

Avoiding category errors in the order file

Procurement systems sometimes inherit a “peptide” category from a neighboring catalog. For NAD+, that shortcut creates avoidable mismatches: the wrong method assumptions, the wrong comparison set, or a report template that does not fit the analyte. Keep the chemical class visible on the internal brief even if a URL or a menu still uses a broader label.

The same discipline applies when a quotation bundles NAD+ with peptide line items. Review the NAD+ row on its own terms: name, specification, quantity basis, and the report that belongs to that row. Do not let a bundle total hide a missing document.

If your organization requires independent testing, say so in the brief and say what you will test. A supplier’s existing report and your own confirmatory work are complementary records. One does not automatically replace the other.

When you archive the lot file, store the catalog specification, the report, and the receiving record under the NAD+ name your organization uses internally, with a cross-reference to the supplier SKU. That small filing habit makes later comparisons faster and reduces the chance that a “peptide” folder label hides a different class of material.

Sourcing notes for qualified buyers

Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.

Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.

Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.

My inquiry listNo products added yet0